A Research Study to Compare Blood Levels of Cagrilintide and Semaglutide After Single Doses of Different Versions of Injectable CagriSema in Adults With Overweight or Obesity

NCT06716307 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

18

Enrollment

INDUSTRY

Sponsor class

Conditions

Obesity

Interventions

DRUG: CagriSema (cagrilintide B and semaglutide I)
DRUG: CagriSema A

Sponsor

Novo Nordisk A/S